Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$6.01 - $8.35 $1.32 Million - $1.83 Million
218,900 Added 167.48%
349,600 $2.92 Million
Q3 2022

Nov 14, 2022

BUY
$5.57 - $7.46 $388,229 - $519,962
69,700 Added 114.26%
130,700 $742,000
Q2 2022

Aug 15, 2022

BUY
$5.65 - $12.19 $122,605 - $264,523
21,700 Added 55.22%
61,000 $345,000
Q1 2022

May 16, 2022

SELL
$10.93 - $14.05 $475,455 - $611,175
-43,500 Reduced 52.54%
39,300 $478,000
Q4 2021

Feb 14, 2022

SELL
$12.24 - $16.31 $948,600 - $1.26 Million
-77,500 Reduced 48.35%
82,800 $1.13 Million
Q3 2021

Nov 15, 2021

SELL
$14.72 - $20.66 $298,816 - $419,398
-20,300 Reduced 11.24%
160,300 $2.52 Million
Q2 2021

Aug 16, 2021

BUY
$17.91 - $22.41 $1.21 Million - $1.51 Million
67,400 Added 59.54%
180,600 $3.7 Million
Q1 2021

May 17, 2021

BUY
$16.11 - $20.55 $49,941 - $63,705
3,100 Added 2.82%
113,200 $1.97 Million
Q4 2020

Feb 16, 2021

SELL
$12.76 - $18.33 $19,140 - $27,494
-1,500 Reduced 1.34%
110,100 $1.92 Million
Q3 2020

Nov 16, 2020

SELL
$9.07 - $14.82 $98,863 - $161,538
-10,900 Reduced 8.9%
111,600 $1.6 Million
Q2 2020

Aug 14, 2020

SELL
$7.16 - $12.33 $168,260 - $289,755
-23,500 Reduced 16.1%
122,500 $1.28 Million
Q1 2020

May 15, 2020

BUY
$6.08 - $16.42 $407,360 - $1.1 Million
67,000 Added 84.81%
146,000 $1.19 Million
Q4 2019

Feb 14, 2020

BUY
$10.57 - $13.84 $435,484 - $570,208
41,200 Added 108.99%
79,000 $949,000
Q3 2019

Nov 14, 2019

BUY
$10.51 - $13.32 $28,377 - $35,964
2,700 Added 7.69%
37,800 $462,000
Q2 2019

Aug 14, 2019

BUY
$12.7 - $15.49 $44,450 - $54,215
3,500 Added 11.08%
35,100 $465,000
Q1 2019

May 15, 2019

BUY
$13.93 - $17.91 $440,188 - $565,956
31,600 New
31,600 $477,000

Others Institutions Holding SPNE

About SeaSpine Holdings Corp


  • Ticker SPNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,202,800
  • Description
  • SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion pr...
More about SPNE
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.